Bilcare Research brings multiphase stability and shelf-life testing to drug developers as a step to choosing the right blister-card materials
It is common practice to perform stability testing of pharma tablets as part of the drug-approval process, but frequently, a nonscientific choice has been made for the films and foils used to package that tablet going into the testing. Now, Bilcare Research (Delaware City, DE) is offering a comprehensive testing service, called BilcareOptima, to address these concerns. By performing a raft of separate tests, Bilcare can help the manufacturer choose the right materials for both performance and economics. In some cases, the testing can play a role in determining the final formulation of the product. With the steady stream of product recalls and failed packaging afflicting the industry right now, the timing couldn’t be better. (The latest packaging snafu, announced last week, involved Glenmark Generics of Mahwah, NJ, which has initiated a recall of incorrectly sequenced norgestimate and ethinyl estradiol birth-control pills; this is not to be confused with the earlier packaging problems of Pfizer for its birth control products.)
BilcareOptima comprises a minimum of eight separate tests, all of which meet ICH quality standards, and some of which include proprietary Bilcare technology, according to Dr. Ajith Nair, head of global R&D:
• Physical degradation
• Hygroscopicity
• Chemical degradation
• Drug release properties
• Hardness and friability
• Photosensitivity
• Gas liberation
• Material-product interaction
When this round of testing is complete, Bilcare can recommend the best choices for packaging materials, either to meet a desired shelf life, or to address potential problems such as humidity or oxidation effects. The technology isn't new; Bilcare has been performing this testing in its facilities in India and Singapore for several years, but has now equipped the Delaware City plant to perform it. "We would hope that a client would then go on to take advantage of Bilcare’s full range of packaging materials and services after the testing is done, but that’s not a requirement," says John Zripko, SVP, pharma, at Bilcare. The company offers common packaging films such as PVC, PVDC, Honeywell's Aclar film, cold forming foils and specialty products. Additionally, Bilcare offers computer-aided design services for blister cavity and card design, and a joint venture with MeadWestVaco, International Labs of St. Petersburg, FL, to perform contract packaging.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.